Intech Investment Management LLC Nektar Therapeutics Transaction History

Intech Investment Management LLC

  • $10.8 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 20, 2025
BUY
$0.66 - $1.19 $23,195 - $41,821
35,144 Added 42.94%
116,990 $79,000
Q4 2024

Feb 10, 2025
BUY
$0.9 - $1.45 $45,537 - $73,365
50,597 Added 161.92%
81,846 $76,000
Q3 2024

Nov 08, 2024
BUY
$1.11 - $1.48 $34,686 - $46,248
31,249 New
31,249 $40,000

Others Institutions Holding NKTR

# of Institutions
19
Shares Held
15.6M
Call Options Held
0
Put Options Held
0
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $10.6B
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email